Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness.
Strategic focus
The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by:
rising prevalence of retinal disease due to aging pop...
Oxular develops novel drug/device combination treatments for sight threatening retinal diseases. The Company’s innovative technology enables sustained drug release, better delivery, and reduced side effects, while improving therapeutic effectiveness.
Strategic focus
The global retinal therapeutics market is set to surpass $14 billion by 2024. Growth is being driven by:
rising prevalence of retinal disease due to aging populations and the increasing incidence of diabetes;
approval of new and longer lasting treatments;
better drug delivery; & better access to healthcare globally
Oxular’s development pipeline includes treatments.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.